Effects of levosimendan in patients with acute heart failure and cardiorenal syndrome

FUNDING ACKNOWLEDGEMENTS: Type of funding sources: None. INTRODUCTION: Cardiorenal syndrome (CRS) is common in patients with acute heart failure (AHF) and is associated with poor prognosis. Levosimendan (LVS) is an inodilator used in AHF and has beneficial effects on renal function (RF). However, it...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Eur Heart J Acute Cardiovasc Care
Prif Awduron: Ribeiro Da Silva, M, Santos Silva, G, Caeiro, D, Passos Silva, M, Guerreiro, C, Teixeira, P, Ribeiro Queiros, P, Brandao, M, Ferreira, D, Sousa, O, Dias, A, Rodrigues, A, Braga, P
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Oxford University Press 2021
Pynciau:
16.4.1 - Pharmacotherapy
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC8264012/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ehjacc/zuab020.028
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg